Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy
- PMID: 20012500
- PMCID: PMC2840675
- DOI: 10.1245/s10434-009-0859-9
Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy
Comment on
-
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.Ann Surg Oncol. 2010 Apr;17(4):981-90. doi: 10.1245/s10434-009-0743-7. Epub 2010 Jan 20. Ann Surg Oncol. 2010. PMID: 20087786 Free PMC article.
References
-
- Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the Pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567–79. - PubMed
-
- Takai S, Satoi S, Toyokawa H, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243–9. - PubMed
-
- Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324–9. - PubMed
-
- Regine W, Winter K, Abrams R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol. 2006;24:4007.
-
- Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical